B
oston's life sciences and biotech sectors are at a crossroads, with shifting landscapes and emerging trends poised to reshape the industry. On April 17, 2025, Boston Real Estate Times and Life Sciences Times will host an exclusive conference that brings together six visionary leaders for a pivotal discussion on the future of biotech innovation and real estate strategy.
The event, held at the Burlington Marriott Hotel in Massachusetts, will explore the intersection of life sciences, biotech, and medical facilities. As the Greater Boston market navigates new challenges and opportunities, this gathering will provide unparalleled insights into the evolving landscape.
A distinguished panel of industry experts includes:
Purnanand Sarma, Ph.D., CEO of Aro Biotherapeutics, a pioneer in siRNA-based therapeutics with over 30 years of experience in biotech and pharmaceuticals. His expertise spans successful IPOs, M&A transactions, and strategic asset development.
Ben Bradford, Vice President of Economic Development and Workforce at Mass Biotech Council, will share his insights on economic development, workforce trends, and the evolving industry landscape. With a wealth of experience in attracting and expanding biotech businesses, he is a key resource for companies seeking to grow in Massachusetts.
Robert Doherty, Vice President of Development at Boston Development Group, brings over 35 years of real estate expertise, including a tenure at Related Companies and international work with EMC. He will discuss how the Boston life sciences real estate market can adapt, recover, and thrive amid economic and policy shifts.
Gary Kaufman, COO of ABI-LAB, is a biotech incubation pioneer who has fostered early-stage innovation and developed an investment vehicle to fund emerging biotech companies. His session will offer unique investment perspectives and strategies for building successful biotech ventures.
Jonathan Cocker, Principal at Maugel DeStefano Architects, will explore cutting-edge advancements in designing next-generation medical and life sciences facilities, covering hospital navigation, flexible spaces, sustainable buildings, and technology integration.
Samuel Crossman, Managing Director at JLL, is a leading voice in life science real estate with expertise in tenant representation assignments for companies like Delphia Therapeutics and WuXi Biologics. He currently leads over one million square feet of life science projects across Greater Boston.
This conference promises:
Unmatched industry expertise from top executives, investors, and developers shaping the future of biotech, pharma, and healthcare infrastructure.
Exclusive market insights on the Boston life sciences real estate market, emerging biotech investment opportunities, and the impact of evolving healthcare policies.
Powerful networking opportunities with leading investors, CEOs, developers, architects, and policymakers in the life sciences, biotech, and medical real estate industries.
Secure your spot today to stay ahead of the curve in this high-impact event!
